raulin
report
first
time
zinc
essenti
growth
microorgan
mani
year
later
zinc
recogn
growth
factor
plant
zinc
shown
essenti
growth
rat
todd
et
al
zinc
shown
essenti
growth
poultri
howev
zinc
consid
essenti
human
health
scientist
consid
improb
zinc
defici
human
would
lead
signific
clinic
problem
dogma
chang
studi
establish
first
time
zinc
essenti
human
health
defici
occur
middl
east
prasad
et
al
current
estim
world
health
organ
nearli
billion
subject
develop
world
may
affect
zinc
defici
popul
live
villag
develop
world
subsist
cereal
protein
diet
high
phytat
organ
phosphat
compound
render
zinc
unavail
absorpt
acquir
defici
zinc
report
mani
diseas
cirrhosi
liver
chronic
renal
diseas
malabsorpt
syndrom
chronic
alcohol
sickl
cell
diseas
chronic
diseas
includ
malign
prasad
major
clinic
effect
zinc
defici
human
includ
sever
growth
retard
hypogonad
cellmedi
immun
dysfunct
increas
oxid
stress
upregul
inflammatori
cytokin
product
problem
heal
impair
cognit
function
earli
knew
three
enzym
carbon
anhydras
alcohol
dehydrogenas
carboxypeptidas
requir
zinc
activ
prasad
prasad
today
know
enzym
zinc
depend
present
know
transcript
factor
requir
gene
express
variou
protein
need
zinc
mainten
structur
bind
dna
moreov
zinc
known
second
messeng
immun
cell
zinc
essenti
cellmedi
immun
zinc
antioxid
antiinflammatori
agent
prasad
intracellular
zinc
level
tightli
control
homeostasi
know
zip
znt
transport
prasad
chapter
present
brief
histori
zinc
discov
essenti
element
human
impact
discoveri
human
health
biomark
zinc
defici
train
clinicalscientist
univers
minnesota
depart
medicin
dr
cj
watson
clinicalscientist
program
start
medic
school
world
war
ii
purpos
train
physician
clinic
medicin
also
basic
scienc
clinicalscientist
could
investig
clinic
problem
research
laboratori
understand
basic
mechan
involv
clinic
disord
type
train
program
truli
advanc
knowledg
rapidli
unit
state
train
mani
leader
medicin
around
world
follow
train
dr
watson
contact
prof
ha
reimann
chief
medicin
jefferson
medic
school
philadelphia
prof
reimann
person
friend
physician
shah
iran
accept
posit
chief
medicin
univers
shiraz
medic
school
shiraz
iran
professor
reimann
want
join
shiraz
help
set
medic
curriculum
shiraz
medic
school
pattern
american
medic
school
initi
reluct
make
move
minneapoli
shiraz
prof
reimann
persuas
accept
offer
stori
zinc
began
iranian
physician
present
medic
center
grand
round
male
look
like
boy
sever
anem
genitalia
infantil
rough
dri
skin
mental
lethargi
hepatosplenomegali
geophagia
ate
bread
made
whole
wheat
flour
intak
anim
protein
consum
kg
clay
daili
sever
iron
defici
blood
loss
later
discov
syndrom
common
villag
shiraz
iran
prasad
et
al
iron
defici
alon
could
account
featur
observ
case
inasmuch
growth
retard
testicular
atrophi
seen
irondefici
experiment
anim
examin
period
tabl
suggest
defici
anoth
transit
element
perhap
zinc
may
also
present
could
account
growth
retard
hypogonad
consid
possibl
high
phosphat
content
diet
geophagia
may
decreas
bioavail
iron
zinc
result
defici
element
prasad
et
al
later
studi
egypt
document
conclus
zinc
defici
occur
human
zinc
supplement
result
inch
growth
year
genitalia
becam
normal
within
month
zinc
supplement
prasad
et
al
sandstead
et
al
nearli
one
decad
possibl
zinc
defici
occur
human
remain
controversi
sever
report
howev
support
idea
nation
research
council
nation
academi
scienc
declar
zinc
essenti
element
human
establish
recommend
dietari
allow
rda
zinc
prasad
prasad
us
food
drug
administr
fda
made
mandatori
includ
zinc
total
parenter
nutrit
fluid
prasad
prasad
detail
circumst
lead
discoveri
human
zinc
defici
middl
east
publish
sandstead
barn
moynahan
report
girl
sever
acrodermat
enteropathica
ae
treat
diiodohydroxi
quinolon
lactosedefici
synthet
diet
show
respons
therapi
serum
zinc
concentr
significantli
decreas
administ
oral
zinc
sulfat
correct
defici
surprisingli
skin
lesion
gastrointestin
symptom
clear
therapi
zinc
inadvert
omit
child
regimen
child
suffer
relaps
howev
complet
respond
oral
zinc
therapi
author
realiz
zinc
might
fundament
pathogenesi
rare
inherit
disord
clinic
improv
reflect
correct
zinc
statu
patient
origin
observ
quickli
confirm
patient
ae
throughout
world
underli
pathogenesi
zinc
defici
patient
due
malabsorpt
zinc
caus
mutat
intestin
zinc
transport
wang
et
al
ae
lethal
autosom
recess
trait
usual
occur
infant
italian
american
iranian
lineag
prasad
diseas
develop
earli
month
life
soon
wean
breast
feed
dermatolog
manifest
sever
zinc
defici
patient
ae
includ
bullou
pustular
dermat
extrem
oral
anal
genit
area
around
orific
paronychia
alopecia
ophthalm
sign
includ
blephar
conjunct
photophobia
corneal
opac
neuropsychiatr
sign
includ
irrit
emot
instabl
tremor
occasion
cerebellar
ataxia
weight
loss
growth
retard
male
hypogonad
also
promin
clinic
featur
congenit
malform
fetus
infant
born
pregnant
women
ae
observ
commonli
prasad
prasad
ae
patient
increas
suscept
infect
thymic
hypoplasia
absenc
germin
center
lymph
node
plasmacytosi
spleen
seen
consist
tcellmedi
function
abnorm
complet
correct
zinc
supplement
clinic
cours
downhil
failur
thrive
complic
intercurr
bacteri
fungal
viral
opportunist
infect
gastrointestin
disturb
sever
includ
diarrhea
malabsorpt
steatorrhea
lactos
intoler
diseas
unrecogn
untreat
fatal
zinc
supplement
result
complet
recoveri
ae
gene
local
cm
region
chromosom
gene
encod
histidinerich
protein
refer
member
larg
famili
transmembran
protein
known
zinc
transport
patient
ae
mutat
gene
demonstr
wang
et
al
kay
tasmanjon
report
occurr
sever
zinc
defici
subject
receiv
total
parenter
nutrit
tpn
prolong
period
without
zinc
okada
et
al
also
report
similar
result
without
zinc
observ
document
sever
investig
inde
unit
state
zinc
routin
includ
tpn
fluid
subject
like
receiv
therapi
extend
period
sever
defici
zinc
also
observ
patient
wilson
diseas
receiv
penicillamin
therapi
decopp
agent
treatment
may
induc
excess
zinc
loss
result
sever
defici
zinc
klingberg
et
al
summari
manifest
sever
zinc
defici
human
includ
bullou
pustular
dermat
alopecia
diarrhea
emot
disord
weight
loss
intercurr
infect
due
cellmedi
immun
dysfunct
hypogonad
male
neurosensori
disord
problem
heal
ulcer
sever
defici
zinc
untreat
fatal
manifest
moder
defici
zinc
includ
growth
retard
male
hypogonad
adolesc
rough
skin
poor
appetit
mental
lethargi
delay
wound
heal
cellmedi
immun
dysfunct
abnorm
neurosensori
chang
manifest
report
subject
nutrit
defici
zinc
prasad
et
al
prasad
et
al
prasad
prasad
subject
acquir
defici
zinc
appar
nutrit
defici
zinc
human
preval
throughout
world
particularli
area
cereal
protein
primari
local
diet
turkey
geophagia
also
common
major
adolesc
villag
turkey
geophagia
exhibit
iron
zinc
defici
prasad
prasad
cavdar
et
al
cavdar
et
al
observ
decreas
plasma
zinc
level
almost
low
socioeconom
statu
pregnant
women
turkey
diet
consist
mainli
cereal
matern
zinc
defici
associ
sever
congenit
malform
central
nervou
system
fetus
matern
morbid
increas
although
clinic
biochem
diagnost
aspect
sever
moder
level
zinc
defici
human
well
defin
recognit
mild
defici
zinc
remain
difficult
problem
therefor
develop
experiment
model
zinc
defici
human
defin
mild
defici
zinc
group
human
volunt
induc
mild
defici
zinc
dietari
mean
adult
male
volunt
kept
clinic
research
center
univers
michigan
medic
school
hospit
ann
arbor
michigan
semipurifi
diet
suppli
approxim
mg
zinc
daili
use
induc
zinc
defici
prasad
et
al
prasad
et
al
beck
et
al
b
volunt
given
hospit
diet
contain
adequ
anim
protein
daili
week
diet
suppli
approxim
mg
zinc
daili
consist
rda
follow
receiv
mg
zinc
daili
consum
soyprotein
base
experiment
diet
regim
continu
week
follow
volunt
receiv
two
cooki
contain
mg
supplement
zinc
supplement
continu
week
throughout
studi
level
nutrient
includ
protein
amino
acid
vitamin
miner
micro
macro
element
kept
constant
meet
rda
except
zinc
techniqu
abl
induc
specif
mild
defici
zinc
human
volunt
result
mild
zinc
defici
observ
decreas
serum
testosteron
level
oligospermia
decreas
natur
killer
nk
cell
lytic
activ
decreas
activ
helper
cell
decreas
serum
thymulin
activ
hyperammonemia
hypogeusia
decreas
dark
adapt
decreas
lean
bodi
mass
prasad
et
al
prasad
et
al
beck
et
al
b
studi
clearli
establish
even
mild
defici
zinc
human
affect
clinic
biochem
immunolog
function
advers
zinc
second
messeng
immun
cell
intracellular
zinc
particip
signal
event
hirano
et
al
kitamura
et
al
haas
rink
rosenkranz
et
al
hirano
et
al
hirano
et
al
kitamura
et
al
haas
rink
rosenkranz
et
al
shown
decreas
intracellular
free
zinc
critic
lipopolysaccharid
lp
mediat
cd
tcell
activ
dendrit
cell
dc
lp
bind
dc
initi
trifmedi
signal
domain
contain
adapterinduc
hirano
et
al
kitamura
et
al
haas
rink
rosenkranz
et
al
trifmedi
signal
increas
mrna
decreas
mrna
thu
result
decreas
intracellular
free
zinc
dc
reduct
intracellular
free
zinc
increas
surfac
express
major
histocompat
complex
mhc
class
ii
molecul
import
activ
cd
tcell
hirano
et
al
kitamura
et
al
moreov
zinc
affect
activ
monocyt
macrophag
sever
way
zinc
requir
monocytemacrophag
develop
shankar
prasad
prasad
et
al
prasad
et
al
bao
et
al
bao
et
al
regul
variou
function
phagocytosi
proinflammatori
cytokin
product
lp
stimul
zincsuffici
monocyt
result
downregul
inflammatori
cytokin
tumor
necrosi
factor
tnf
shankar
prasad
prasad
et
al
prasad
et
al
bao
et
al
bao
et
al
zinc
inhibit
cell
membran
phosphodiesteras
lead
elev
level
second
messeng
cgmp
follow
subsequ
suppress
mrna
inflammatori
cytokin
shankar
prasad
prasad
et
al
prasad
et
al
bao
et
al
bao
et
al
addit
zinc
induc
inhibit
signal
via
tnf
receptorassoci
pathway
result
downregul
mrna
encod
inflammatori
cytokin
prasad
et
al
bao
et
al
base
find
propos
zinc
import
antiinflammatori
agent
zinc
defici
also
affect
function
advers
human
beck
et
al
b
prasad
et
al
serum
thymulin
activ
gener
cytokin
affect
within
week
institut
zincrestrict
diet
mg
daili
human
wherea
plasma
zinc
decreas
week
institut
experiment
diet
suggest
cell
sensit
zinc
restrict
cytokin
affect
zinc
defici
human
malign
lymphoblastoid
cell
line
cell
show
zincsuffici
cell
mrna
level
tbet
phorbol
myrist
acet
pma
phytohemagglutininp
pha
stimul
cell
increas
comparison
zincdefici
cell
although
intracellular
free
zinc
increas
slightli
pmaphastimul
cell
con
astimul
cell
zincsuffici
medium
increas
sustain
level
intracellular
free
zinc
comparison
zincdefici
cell
conclud
stimul
cell
con
via
tcell
receptor
tcr
releas
intracellular
free
zinc
function
signal
transduct
molecul
gener
tbet
mrna
requir
cell
differenti
supplement
zinc
shown
prevent
treat
diarrhea
among
children
year
age
decreas
diarrhea
mortal
sazaw
et
al
fisher
walker
et
al
zinc
defici
also
correl
risk
respiratori
tract
infect
benefit
supplement
appear
limit
sever
episod
popul
high
incid
zinc
defici
fisher
walker
et
al
diarrhea
caus
breakdown
absorpt
mucosa
result
poor
absorpt
nutrient
includ
zinc
prior
studi
link
diarrheal
ill
loss
endogen
zinc
fisher
walker
et
al
children
low
plasma
zinc
observ
suscept
diarrhea
propag
cycl
defici
infect
extens
evid
support
efficaci
zinc
supplement
prevent
childhood
diarrhea
fisher
walker
et
al
issu
global
recommend
daili
supplement
mg
zinc
children
month
mg
zinc
infant
month
day
upon
diarrheal
onset
metaanalysi
routin
supplement
month
seven
studi
provid
one
two
time
rda
element
zinc
five
seven
time
per
week
found
reduct
diarrheal
incid
decreas
diarrhea
preval
reduct
persist
diarrhea
episod
among
supplement
children
compar
children
receiv
placebo
fisher
walker
et
al
metaanalysi
three
random
control
trial
provid
short
cours
zinc
supplement
two
four
time
daili
rda
week
follow
onset
episod
acut
persist
diarrhea
report
pool
analysi
show
decreas
diarrhea
incid
decreas
diarrhea
preval
observ
period
common
cold
one
frequent
occur
diseas
world
prasad
et
al
virus
caus
common
cold
includ
rhinovirus
corona
virus
adenovirus
respiratori
syncyti
viru
parainfluenza
virus
annual
adult
unit
state
may
suffer
two
four
time
common
cold
children
may
develop
cold
six
eight
time
year
morbid
subsequ
financi
loss
result
absente
work
substanti
previous
prescrib
treatment
provid
consist
relief
symptom
test
efficaci
zinc
acet
lozeng
common
cold
volunt
recruit
within
h
develop
symptom
common
cold
carri
random
doubleblind
placebocontrol
trial
prasad
et
al
particip
took
one
lozeng
contain
mg
zinc
zinc
acet
placebo
everi
h
awak
soon
develop
common
cold
symptom
subject
symptom
score
sore
throat
nasal
discharg
nasal
congest
sneez
cough
scratchi
throat
hoars
muscl
ach
fever
headach
record
daili
day
plasma
zinc
proinflammatori
cytokin
assay
day
particip
well
twentyf
zinc
group
placebo
group
complet
studi
compar
placebo
group
zinc
group
shorter
overal
durat
cold
symptom
vs
day
p
cough
vs
day
p
nasal
discharg
vs
day
p
decreas
total
sever
score
symptom
p
anoth
studi
recruit
ambulatori
volunt
within
h
develop
common
cold
symptom
random
doubleblind
placebocontrol
trial
zinc
particip
took
one
lozeng
contain
mg
zinc
zinc
acet
placebo
everi
h
awak
subject
score
clinic
symptom
record
daili
plasma
zinc
solubl
interleukin
il
receptor
antagonist
solubl
tumor
neurosi
factor
receptor
solubl
vascular
endotheti
cell
adhes
molecul
assay
day
compar
placebo
group
zinc
group
shorter
mean
overal
durat
cold
vs
day
p
shorter
durat
cough
vs
day
p
nasal
discharg
vs
day
p
symptom
sever
score
also
significantli
decreas
zinc
group
p
mean
chang
zinc
placebo
group
vs
therapi
show
signific
differ
p
level
p
decreas
zinctreat
group
mean
chang
zinc
placebo
group
vs
therapi
show
signific
differ
p
result
suggest
common
cold
virus
increas
oxid
stress
activ
macrophag
monocyt
zinc
decreas
activ
monocyt
macrophag
decreas
oxid
stress
previous
shown
zinc
function
antioxid
prasad
et
al
bao
et
al
human
rhinoviru
type
dock
surfac
somat
cell
prasad
et
al
result
show
zinc
may
act
antivir
agent
reduc
level
report
zinc
function
downregul
activ
involv
gene
express
adhes
molecul
conclud
zinc
acet
lozeng
given
within
h
onset
common
cold
proper
dosag
effect
decreas
durat
sever
common
cold
propos
benefici
effect
seen
zinc
group
due
antioxid
antiinflammatori
effect
zinc
also
suggest
decreas
plasma
level
due
zinc
therapi
may
decreas
dock
cold
virus
surfac
somat
cell
metaanalysi
select
random
doubleblind
placebocontrol
trial
use
zinc
least
consecut
day
treat
least
month
prevent
common
cold
includ
analysi
singh
da
thirteen
therapeut
trial
particip
two
prevent
trial
particip
includ
analysi
studi
report
zinc
significantli
reduc
overal
durat
sever
common
cold
symptom
therapi
start
within
h
onset
cold
critic
solut
chemistri
zinc
prepar
dose
must
proper
zinc
therapi
must
begin
within
h
onset
cold
symptom
total
daili
dose
element
zinc
greater
mg
chemic
formul
optim
zinc
ioniz
oral
caviti
ph
zinc
acet
zinc
glucon
good
salt
use
howev
citric
acid
glycin
tartar
binder
present
zinc
prevent
ioniz
physician
health
practition
must
realiz
one
treat
common
cold
symptom
swallow
zinc
tablet
zinc
syrup
zinc
lozeng
zinc
lozeng
must
use
oral
allow
dissolv
slowli
mouth
allow
ionic
zinc
releas
absorb
transport
viral
infect
nose
studi
document
occurr
zinc
defici
adult
sickl
cell
diseas
scd
patient
prasad
et
al
bao
et
al
growth
retard
hypogonad
male
hyperammonemia
abnorm
dark
adapt
cellmedi
immun
dysfunct
scd
patient
relat
defici
zinc
biochem
evid
zinc
defici
scd
patient
decreas
level
zinc
plasma
erythrocyt
hair
hyperzincuria
decreas
activ
certain
zincdepend
enzym
carbon
anhydras
erythrocyt
alkalin
phosphatas
neutrophil
deoxythymidin
kinas
activ
newli
synthes
skin
connect
tissu
collagen
hyperammonemia
prasad
et
al
bao
et
al
inasmuch
zinc
known
inhibitor
ribonucleas
rnase
increas
activ
enzym
plasma
consid
also
evid
zinc
defici
zinc
supplement
scd
patient
result
signific
improv
secondari
sexual
characterist
normal
plasma
ammonia
level
correct
dark
adapt
abnorm
zinc
supplement
also
increas
zinc
level
plasma
erythrocyt
neutrophil
expect
respons
zinc
supplement
enzym
activ
also
observ
increas
longitudin
growth
bodyweight
scd
patient
observ
zinc
supplement
also
correct
impair
delay
type
hypersensit
decreas
nk
cell
lytic
activ
scd
patient
prasad
et
al
bao
et
al
placebocontrol
zinc
supplement
trial
mg
zinc
zinc
acet
three
time
day
scd
patient
show
zincsuppl
subject
decreas
incid
infect
increas
hemoglobin
hematocrit
level
increas
plasma
zinc
antioxid
power
comparison
placebo
group
plasma
nitrit
nitrat
nox
lipid
peroxid
product
dna
oxid
product
solubl
vascular
cell
adhes
decreas
zincsuppl
group
comparison
placebo
group
zincsuppl
subject
show
signific
decreas
lpsinduc
mrna
tnfinduc
nuclear
factor
bind
mnc
compar
placebo
group
zinc
supplement
also
increas
rel
level
mrna
phap
stimul
mnc
moreov
cochran
review
swe
et
al
conclud
zinc
therapi
modal
effect
decreas
incid
infect
pain
crise
scd
patient
wilson
diseas
inherit
autosom
disord
copper
accumul
excret
liver
copper
bile
decreas
lead
failur
proper
copper
excret
stool
lead
accumul
copper
liver
eventu
liver
also
brain
organ
damag
due
excess
copper
accumul
patient
typic
present
liver
diseas
neurolog
diseas
movement
disord
psychiatr
disturb
second
fourth
decad
life
mani
case
diagnosi
either
miss
delay
brew
yuzbasiyangurkan
brewer
brewer
et
al
gene
wilson
diseas
identifi
genet
mutat
lead
defect
product
protein
call
respons
key
step
biliari
excret
copper
brew
yuzbasiyangurkan
brewer
brewer
et
al
diseas
recess
thu
copi
gene
mutat
caus
failur
biliari
excret
copper
produc
diseas
larg
number
mutat
gene
caus
wilson
diseas
identifi
earli
diagnosi
wilson
diseas
import
inasmuch
effect
therapeut
measur
may
prevent
accumul
copper
seriou
damag
organ
liver
brain
nineti
percent
wilson
diseas
patient
low
level
ceruloplasmin
ceruloplasminbound
copper
nonceruloplasminbound
copper
elev
plasma
measur
h
urinari
copper
good
diagnost
test
consist
elev
patient
brew
yuzbasiyangurkan
brewer
brewer
et
al
urinari
copper
howev
may
elev
patient
obstruct
liver
diseas
also
wilson
diseas
slit
lamp
examin
corneal
copper
deposit
kayserfleisch
ring
use
noninvas
diagnost
test
wilson
diseas
howev
posit
case
initi
treatment
object
decreas
copper
burden
also
desir
prevent
copper
shift
one
pool
decopp
done
initi
copper
control
treatment
may
take
month
brew
yuzbasiyangurkan
brewer
brewer
et
al
sever
year
ago
use
mg
element
zinc
six
divid
dose
treatment
scd
patient
prasad
et
al
observ
zinc
effect
antisickl
drug
observ
howev
level
zinc
therapi
defici
copper
induc
patient
led
brewer
et
al
brew
yuzbasiyangurkan
brewer
brewer
et
al
develop
zinc
effect
anticopp
drug
wilson
diseas
zinc
compet
copper
similar
bind
site
oral
zinc
effici
decreas
uptak
copper
hall
et
al
zinc
may
act
induct
intestin
cell
metallothionein
mt
mt
induc
high
affin
bind
copper
prevent
seros
transfer
copper
blood
intestin
cell
turn
rapidli
take
complex
copper
stool
final
excret
zinc
block
food
copper
also
copper
endogen
excret
via
salivari
gastric
gastrointestin
juic
thu
zinc
effect
produc
neg
copper
balanc
fifti
milligram
element
zinc
acet
given
oral
three
time
day
manag
wilson
diseas
patient
zinc
given
fast
postabsorpt
state
side
effect
subject
may
gastric
discomfort
usual
observ
first
morn
dose
avoid
zinc
administ
breakfast
lunch
dinner
go
bed
zinc
drug
choic
mainten
therapi
brew
yuzbasiyangurkan
brewer
brewer
et
al
zinc
toxic
nonteratogen
thu
given
subject
age
even
pregnant
women
zinc
approv
fda
treatment
wilson
diseas
patient
agerel
macular
degener
amd
affect
nearli
subject
year
age
latestag
diseas
account
nearli
legal
blind
europ
north
america
newsom
et
al
newsom
et
al
demonstr
concentr
zinc
reduc
human
eye
sign
amd
suggest
zinc
defici
may
led
oxid
stress
retin
damag
agerel
eye
diseas
studi
group
are
support
nation
eye
institut
nation
institut
health
nih
conduct
doublemask
clinic
trial
patient
drytyp
amd
agerel
eye
diseas
studi
research
group
are
report
total
particip
enrol
age
rang
year
averag
followup
period
year
particip
randomli
assign
receiv
daili
oral
one
follow
antioxid
vitamin
c
mg
vitamin
e
iu
beta
caroten
mg
zinc
mg
zinc
oxid
copper
mg
copper
oxid
prevent
copper
defici
induc
zinc
antioxid
plu
zinc
placebo
group
take
antioxid
plu
zinc
reduc
risk
develop
advanc
amd
vision
loss
group
take
zinc
alon
reduc
risk
develop
advanc
amd
vision
loss
group
take
vitamin
alon
risk
develop
advanc
amd
decreas
vision
loss
decreas
signific
side
effect
note
group
receiv
high
level
therapeut
zinc
agerel
eye
diseas
studi
research
group
are
report
zincsuppl
group
show
increas
longev
are
report
agerel
eye
diseas
studi
research
group
are
report
risk
mortal
reduc
are
studi
subject
receiv
therapeut
zinc
daili
micronutri
known
similar
effect
mortal
later
public
are
group
observ
decreas
mortal
due
decreas
cardiovascular
event
are
report
agerel
eye
diseas
studi
research
group
are
report
daili
intak
zinc
elderli
subject
western
world
includ
unit
state
around
mg
wherea
rda
mg
elderli
subject
frequent
eat
usual
three
meal
day
may
skip
either
breakfast
lunch
mani
live
alon
cook
proper
meal
studi
detroit
area
shown
welltodo
ambulatori
elderli
subject
may
defici
zinc
result
third
nation
health
nutrit
examin
survey
also
report
elderli
person
year
greatest
risk
inadequ
zinc
intak
bao
et
al
prasad
et
al
prasad
et
al
oxid
stress
increas
inflammatori
cytokin
recogn
import
contribut
factor
sever
chronic
diseas
attribut
age
atherosclerosi
relat
cardiovascular
disord
mutagenesi
cancer
neurodegen
disord
type
diabet
alzheim
diseas
togeth
h
oh
radic
known
reactiv
oxygen
speci
ro
excess
gener
ro
caus
oxid
stress
inflammatori
cytokin
gener
activ
monocyt
also
known
gener
greater
level
ro
elderli
chronic
inflammatori
process
implic
caus
high
cardiovascular
mortal
bao
et
al
shown
zinc
supplement
subject
age
decreas
oxid
stress
marker
malondehyd
mda
plasma
also
downregul
ex
vivo
induct
mrna
mnc
decreas
induc
activ
bao
et
al
prasad
et
al
also
shown
previous
promyelocyt
leukemia
cell
line
differenti
monocyt
macrophag
phenotyp
respons
pha
zinc
upregul
express
bind
transactiv
factor
dna
result
inhibit
activ
bao
et
al
prasad
et
al
prasad
et
al
inasmuch
zinc
defici
suscept
infect
due
cellmedi
immun
dysfunct
observ
elderli
carri
random
placebocontrol
trial
zinc
supplement
healthi
elderli
subject
year
sex
ethnic
group
st
patrick
senior
citizen
center
detroit
mi
one
subject
zinc
group
drop
second
day
thu
complet
data
subject
zinc
placebo
group
exclus
criteria
follow
life
expect
month
progress
neoplast
diseas
sever
cardiac
dysfunct
signific
kidney
diseas
signific
liver
diseas
subject
compet
mental
zinc
supplement
consist
mg
element
zinc
glucon
daili
month
comparison
baselin
data
younger
subject
age
n
elderli
subject
show
plasma
zinc
lower
percentag
cell
produc
significantli
higher
elderli
subject
prasad
et
al
intercellular
adhes
molecul
vascular
endotheli
cell
adhes
molecul
eselectin
plasma
also
significantli
higher
elderli
gener
cell
known
neg
regul
gener
cell
significantli
higher
elderli
moreov
oxid
stress
marker
significantli
higher
elderli
compar
younger
adult
bao
et
al
prasad
et
al
mean
incid
infect
per
subject
lower
p
zincsuppl
group
versu
placebo
group
plasma
zinc
increas
ex
vivo
gener
decreas
significantli
zinc
group
comparison
placebo
group
prasad
et
al
oxid
stress
biomark
plasma
also
decreas
significantli
zinc
group
comparison
placebo
group
bao
et
al
mnc
isol
zincdefici
elderli
subject
zinc
supplement
increas
ex
vivo
phainduc
mrna
express
plasma
zinc
concentr
comparison
zincdefici
subject
receiv
placebo
prasad
et
al
thu
studi
show
zinc
supplement
mg
element
zinc
daili
elderli
subject
decreas
incid
infect
nearli
follow
supplement
oxid
stress
marker
gener
inflammatori
cytokin
increas
prior
supplement
decreas
significantli
highli
signific
effect
zinc
supplement
elderli
may
impli
zinc
may
prove
excel
agent
prevent
chronic
diseas
age
egypt
select
dwarf
age
year
villag
around
cairo
egypt
exhibit
clinic
featur
syndrom
describ
earlier
prasad
et
al
plasma
zinc
measur
dithizon
techniqu
extrem
precaut
taken
avoid
contamin
assay
zinc
plasma
red
blood
cell
urin
hair
significantli
decreas
comparison
egyptian
control
similar
age
prasad
et
al
util
zn
studi
zinc
metabol
dwarf
plasma
zn
disappear
curv
resolv
five
phase
phase
begin
zero
time
extend
min
phase
ii
extend
min
phase
iii
extend
h
phase
iv
day
phase
v
extend
beyond
day
prasad
et
al
see
tabl
second
third
phase
shorter
dwarf
compar
normal
subject
plasma
zinc
turnov
rate
greater
dwarf
comparison
normal
subject
second
phase
twenti
fourhour
exchang
pool
decreas
dwarf
cumul
excret
zinc
urin
stool
day
also
decreas
dwarf
indic
bodi
conserv
zinc
zincdefici
state
conclud
result
dwarf
zinc
defici
first
demonstr
zinc
defici
occur
human
prasad
et
al
see
tabl
supplement
dwarf
mg
zinc
sulfat
daili
report
growth
rate
subject
approxim
inch
annual
grew
pubic
hair
axillari
hair
within
month
zinc
supplement
genitalia
becam
adultlik
within
month
zinc
supplement
sandstead
et
al
egypt
went
wayn
state
univers
school
medicin
detroit
mi
chief
hematolog
soon
arriv
got
call
walter
slavin
perkinelm
corp
norwalk
ct
told
made
avail
atom
absorpt
spectrophotomet
aa
could
make
life
simpler
could
measur
zinc
plasma
without
difficulti
also
offer
donat
one
instrument
research
truli
overwhelm
receiv
instrument
could
assay
zinc
serum
plasma
later
walter
told
sent
machin
develop
method
measur
zinc
plasma
cell
work
hard
techniqu
final
succeed
publish
method
measur
zinc
plasma
red
bold
cell
urin
prasad
et
al
techniqu
use
global
measur
plasma
zinc
even
problem
plasma
contain
protein
salt
alter
flow
sampl
plasma
zinc
could
measur
compar
standard
solut
zinc
contain
interf
substanc
initi
lyophil
plasma
dissolv
lyophil
plasma
hcl
use
trichloracet
acid
precipit
protein
techniqu
care
work
simplifi
method
publish
prasad
et
al
use
flameless
aa
possibl
use
directli
dilut
plasma
sampl
zinc
assay
present
plasma
zinc
wide
use
biomark
zinc
defici
global
howev
aa
expens
instrument
need
care
mainten
avail
easili
develop
countri
furthermor
plasma
zinc
assay
specif
biomark
zinc
defici
human
inasmuch
plasma
zinc
pool
chang
result
infect
exercis
stress
also
even
slight
hemolysi
increas
plasma
zinc
level
sinc
red
cell
rich
zinc
detroit
develop
human
model
would
allow
us
studi
effect
mild
zincdefici
state
human
also
provid
us
sensit
biomark
zinc
defici
recruit
adult
human
volunt
induct
dietari
zinc
defici
detail
select
subject
protocol
publish
earlier
prasad
et
al
volunt
kept
metabol
ward
clinic
research
center
univers
michigan
medic
school
studi
support
grant
nih
monitor
close
physician
clinic
staff
semipurifi
diet
base
textur
soy
protein
develop
studi
diet
provid
adequ
calcium
protein
fat
essenti
nutrient
accord
rda
except
zinc
prasad
et
al
experi
design
last
week
start
experi
subject
receiv
normal
hospit
diet
provid
mg
zincday
week
week
stabil
phase
semipurifi
diet
serv
supplement
mg
zinc
sulfat
incorpor
cooki
provid
total
mg
zincday
follow
week
subject
enter
deplet
phase
zinc
supplement
discontinu
thu
deplet
phase
dietari
intak
zinc
rang
mgday
follow
replet
phase
week
subject
consum
total
mg
zinc
per
day
model
studi
sever
biomark
zinc
defici
includ
measur
zinc
plasma
red
blood
cell
lymphocyt
granulocyt
urin
assay
follow
enzym
deoxythymidin
kinas
activ
collagen
connect
tissu
harvest
follow
implant
spong
skin
lymphocyt
marker
matur
lymphocyt
neutrophil
alkalin
phosphatas
serum
activ
thymulin
gener
cytokin
assay
mrna
cytokin
stimul
cell
assay
plasma
zinc
aa
techniqu
publish
earlier
prasad
et
al
separ
platelet
lymphocyt
granulocyt
whole
blood
requir
care
procedur
prasad
et
al
platelet
remov
first
plasma
remov
platelet
pool
lymphocyt
granulocyt
separ
discontinu
histopaqu
gradient
wang
et
al
lymphocyt
pool
contamin
platelet
therefor
care
step
taken
remov
platelet
lymphocyt
similarli
granulocyt
pool
problem
similar
respect
contamin
erythrocyt
publish
detail
method
techniqu
abl
measur
zinc
platelet
lymphocyt
granulocyt
accur
wang
et
al
human
experiment
model
zinc
defici
observ
daili
dietari
zinc
intak
volunt
around
mg
plasma
zinc
decreas
week
decreas
zinc
level
lymphocyt
granulocyt
observ
week
zincdefici
diet
report
earlier
deoxythymidin
kinas
zincdepend
enzym
prasad
oberlea
zinc
requir
gene
express
enzym
deoxythymidin
kinas
requir
dna
synthesi
phase
essenti
cell
divis
assay
enzym
need
prolifer
tissu
therefor
implant
spong
skin
volunt
end
zincrestrict
period
end
zinc
replet
result
show
assay
enzym
excel
biomark
zinc
defici
human
prasad
oberlea
test
howev
easi
impract
routin
assay
prasad
oberlea
ecto
nucleotidas
nt
zincdepend
enzym
integr
plasma
membran
protein
present
mammalian
cell
assay
nt
activ
lymphocyt
two
group
subject
meftah
et
al
first
group
subject
mild
state
zinc
defici
assess
zinc
level
lymphocyt
granulocyt
platelet
healthi
otherwis
supplement
mg
zinc
acet
oral
week
second
group
six
subject
normal
human
volunt
mild
defici
zinc
induc
dietari
techniqu
mg
zinc
intak
daili
assay
nt
intact
lymphocyt
incub
label
ionosin
monophosph
substrat
product
substrat
separ
thin
layer
chromatographi
first
group
subject
zinc
defici
decreas
activ
nt
correct
cellular
zinc
level
normal
zinc
supplement
second
group
subject
baselin
data
compar
earli
zinc
deplet
week
late
deplet
period
week
decreas
activ
nt
observ
earli
deplet
phase
zinc
level
lymphocyt
granulocyt
platelet
decreas
significantli
late
zinc
deplet
phase
plasma
zinc
level
chang
even
late
zinc
deplet
phase
studi
thu
show
nt
activ
sensit
use
biomark
human
zinc
defici
decreas
activ
zincdefici
lymphocyt
may
indic
lymphocyt
immatur
human
zinc
defici
meftah
et
al
see
fig
figur
lymphocyt
activ
lymphocyt
mean
sd
zinc
supplement
experi
valu
follow
b
mol
imp
convert
per
lymphocyt
per
hour
versu
mol
imp
convert
per
lymphocyt
per
hour
p
reproduc
meftah
prasad
lee
dy
brewer
gj
ecto
nucleotidas
sensit
indic
human
zinc
defici
j
lab
clin
med
figur
chang
lymphocyt
activ
baselin
earli
zinc
defici
late
zinc
defici
period
experi
ii
activ
mean
sd
mole
imp
lymphocyteshour
baselin
b
versu
earli
defici
period
e
late
defici
period
l
follow
b
versu
e
mol
imp
convert
per
lymphocyt
per
hour
versu
mol
imp
convert
per
lymphocyt
per
hour
versu
mol
imp
convert
per
lymphocyt
per
hour
p
e
versu
l
mol
imp
convert
per
lymphocyt
per
hour
versu
mol
imp
convert
per
lymphocyt
per
hour
p
valu
normal
control
subject
also
shown
mol
imp
convert
per
lymphocyt
per
hour
reproduc
meftah
prasad
lee
dy
brewer
gj
ecto
nucleotidas
sensit
indic
human
zinc
defici
j
lab
clin
med
chang
lymphocyt
activ
baselin
earli
zinc
defici
late
zinc
defici
period
experi
ii
activ
mean
sd
mole
imp
lymphocyteshour
baselin
b
versu
earli
defici
period
e
late
defici
period
l
follow
b
versu
e
mol
imp
convert
per
lymphocyt
per
mol
imp
convert
per
lymphocyt
per
hour
versu
mol
imp
convert
per
per
hour
p
e
versu
l
mol
imp
convert
per
lymphocyt
per
hour
versu
mol
imp
convert
per
lymphocyt
per
hour
p
valu
normal
control
subject
also
shown
mol
imp
convert
per
lymphocyt
per
hour
reproduc
meftah
prasad
lee
dy
brewer
gj
ecto
nucleotidas
sensit
indic
human
zinc
defici
j
lab
clin
med
thymulin
wellcharacter
thymic
hormon
follow
amino
acid
sequenc
pyroglualalysserglnglyglyserasn
thymulin
requir
presenc
zinc
express
biolog
activ
known
two
form
thymulin
exist
first
one
depriv
zinc
biolog
inact
second
one
contain
zinc
biolog
activ
prasad
et
al
zincthymulin
relationship
first
studi
zincdefici
mice
activ
thymulin
level
sera
mice
subject
longterm
margin
zinc
defici
decreas
earli
month
begin
diet
prasad
et
al
howev
level
correct
vitro
addit
zncl
similar
observ
made
sera
obtain
children
suffer
nephrot
syndrom
zinc
defici
low
level
activ
thymulin
sera
correct
vitro
addit
zncl
result
confirm
presenc
inact
hormon
serum
zincdefici
subject
potenti
activ
follow
vitro
zinc
addit
specif
result
confirm
lack
activ
experi
perform
sera
thymectom
mice
patient
digeorg
syndrom
hormon
nonexist
serum
level
biolog
activ
thymulin
evalu
rosett
assay
describ
elsewher
shown
strictli
thymu
specif
prasad
et
al
assay
analyz
convers
rel
azathioprin
az
resist
spleen
cell
adult
thymectom
mice
rosetteform
cell
sensit
az
presenc
thymulincontain
sera
rosett
format
inhibit
az
result
express
log
reciproc
highest
serum
dilut
confer
sensit
az
inhibit
upon
spleen
cell
adult
thymectom
mice
confirm
specif
biolog
activ
measur
determin
repeat
preincub
sera
studi
antithymulin
monoclon
antibodi
specif
antithymulin
immuneadsorb
also
assay
serum
thymulin
activ
three
model
mildli
zincdefici
subject
zinc
supplement
human
volunt
mild
defici
zinc
induc
dietari
mean
zincdefici
adult
scd
patient
medic
student
mildli
zinc
defici
inasmuch
plasma
zinc
level
within
normal
rang
zinc
defici
diagnos
assay
cellular
zinc
lymphocyt
granulocyt
platelet
subject
serum
activ
thymulin
decreas
correct
vivo
vitro
zinc
supplement
suggest
serum
thymulin
activ
assay
sensit
biomark
zinc
defici
prasad
et
al
also
observ
ratio
decreas
gener
decreas
correct
follow
zinc
supplement
inasmuch
thymulin
known
induc
intraand
extrathym
tcell
differenti
studi
provid
possibl
mechan
role
zinc
tcell
function
prasad
et
al
see
fig
major
manifest
human
zinc
defici
includ
growth
retard
immun
defici
cognit
impair
prasad
et
al
prasad
et
al
sandstead
et
al
experi
middl
east
show
zincdefici
dwarf
die
prior
age
year
death
due
varieti
infect
suggest
immun
function
sensit
zinc
statu
studi
experiment
human
model
zinc
defici
show
thymulin
thymic
hormon
import
develop
prolifer
differenti
tcell
affect
advers
even
defici
zinc
mild
prasad
et
al
experiment
human
model
zinc
defici
dietari
zinc
intak
figur
chang
plasma
zinc
earli
late
zinc
defici
period
experi
ii
plasma
zinc
level
mean
sd
baselin
b
versu
earli
zinc
defici
period
e
late
zinc
defici
period
l
follow
b
versu
e
versu
p
b
versu
l
versu
p
e
versu
l
versu
p
valu
plasma
zinc
normal
control
subject
mean
sd
also
shown
reproduc
meftah
prasad
lee
dy
brewer
gj
ecto
nucleotidas
sensit
indic
human
zinc
defici
j
lab
clin
med
restrict
mgday
week
plasma
zinc
declin
mean
sd
dl
although
chang
plasma
zinc
small
signific
decreas
gener
ex
vivo
isol
mnc
observ
beck
et
al
b
prasad
et
al
also
regener
new
lymphocyt
decreas
result
dietari
zinc
restrict
anoth
studi
dietari
zinc
restrict
mgday
level
plasma
zinc
decreas
mean
sd
end
week
zincrestrict
period
moreov
activ
lymphocyt
nt
significantli
decreas
meftah
et
al
zinc
intak
volunt
averag
mgday
decreas
serum
thymulin
activ
observ
week
decreas
seen
period
plasma
zinc
concentr
prasad
et
al
thu
appear
signific
chang
immunolog
function
due
mild
zinc
defici
may
observ
absenc
signific
decreas
plasma
zinc
concentr
suggest
assay
zincdepend
immunolog
function
may
better
indic
human
zinc
defici
human
malign
lymphoblastoid
cell
line
use
studi
effect
zinc
product
phapmaactiv
tcell
prasad
et
al
effect
zinc
transcript
level
specif
prasad
et
al
signific
effect
zinc
gene
express
gener
receptor
also
demonstr
express
gene
decreas
zincdefici
cell
anoth
studi
report
zincdefici
cell
phosphoryl
ubiquitin
bind
dna
significantli
decreas
comparison
zincsuffici
cell
prasad
et
al
zinc
increas
transloc
subunit
cytosol
nucleu
prasad
et
al
also
bind
recombin
dna
cell
zinc
specif
studi
also
show
measur
mrna
peripher
blood
mnc
rtpcr
good
indic
zinc
defici
human
prasad
et
al
zincdefici
cell
mrna
decreas
comparison
zincsuffici
cell
physiolog
amount
figur
thymulin
activ
level
thymulin
activ
sequenti
studi
young
human
volunt
submit
zincrestrict
diet
six
month
follow
zinc
supplement
shown
result
express
reciproc
titer
mean
sem
determin
perform
triplic
reproduc
prasad
meftah
abdallah
j
kaplan
j
brewer
gj
bach
jf
dardenn
serum
thymulin
human
zinc
defici
j
clin
invest
prasad
meftah
abdallah
j
kaplan
j
brewer
gj
bach
jf
dardenn
serum
thymulin
human
zinc
defici
j
clin
invest
zinc
ad
defici
cell
ex
vivo
mrna
express
normal
thu
provid
diagnosi
zinc
defici
also
demonstr
ex
vivo
addit
zinc
effect
specif
inasmuch
essenti
trace
element
could
correct
mrna
express
zincdefici
case
studi
also
show
effect
zinc
gene
express
primari
cell
role
activ
prasad
et
al
see
fig
appear
human
maintain
zinc
homeostasi
increas
effici
zinc
absorpt
decreas
endogen
excret
zinc
subject
shortterm
dietari
zinc
restrict
howev
mild
defici
zinc
human
usual
outcom
chronic
exposur
low
dietari
zinc
mani
month
year
therefor
import
determin
whether
adapt
zinc
homeostasi
short
durat
dietari
zinc
depriv
also
figur
thymulin
activ
restor
normal
thymulin
activ
sera
zincdefici
patient
vitro
addit
zncl
shown
chelat
serum
incub
h
ng
zncl
thymulin
activ
determin
perform
vitro
zinc
addit
individu
sampl
p
p
healthi
volunt
submit
zinc
restrict
b
nonsca
zincdefici
subject
c
sca
zincdefici
subject
reproduc
prasad
meftah
abdallah
j
kaplan
j
brewer
gj
bach
jf
dardenn
serum
thymulin
human
zinc
defici
j
clin
invest
experiment
human
model
activ
chang
activ
result
zinc
restrict
zinc
replet
experiment
human
model
subject
shown
data
point
repres
averag
two
separ
determin
subject
p
ns
subject
p
ns
ns
nonsignific
reproduc
prasad
meftah
abdallah
j
kaplan
j
brewer
gj
bach
jf
dardenn
serum
thymulin
human
zinc
defici
j
clin
invest
figur
mrna
rel
level
mrna
zincdefici
zincsuffici
elderli
subject
human
mnc
isol
zincdefici
zincsuffici
elderli
subject
stimul
pha
h
total
rna
extract
sampl
subject
rtpcr
analysi
data
shown
repres
zincdefici
elderli
subject
zincsuffici
elderli
subject
lane
zinc
defici
zinc
suffici
repres
sampl
result
indic
zincsuffici
subject
higher
level
b
mrna
phastimul
mnc
reproduc
prasad
bao
maintain
prolong
period
dietari
zinc
restrict
assess
effici
zinc
absorpt
well
endogen
zinc
excret
period
dietari
zinc
restrict
molday
human
volunt
use
stabl
zinc
isotop
zn
lee
et
al
studi
show
effici
zinc
absorpt
sustain
decreas
volunt
zincrestrict
diet
continu
six
month
hand
prolong
dietari
zinc
restrict
impair
function
role
endogen
zinc
excret
zinc
homeostasi
observ
signific
reduct
endogen
zinc
excret
restrict
dietari
zinc
continu
end
zincrestrict
period
endogen
zinc
excret
molday
baselin
period
gradual
decreas
mean
level
molday
end
month
dietari
zinc
restrict
subject
receiv
zinc
supplement
endogen
zinc
excret
increas
molday
studi
thu
show
measur
endogen
zinc
excret
may
also
sensit
biomark
human
zinc
defici
lee
et
al
see
figur
mrna
effect
zinc
mrna
elderli
subject
month
supplement
human
mnc
isol
zincdefici
zincsuffici
elderli
subject
receiv
either
zinc
supplement
placebo
month
stimul
pha
h
total
rna
extract
sampl
subject
rtpcr
analysi
lane
one
two
three
four
repres
zincdefici
zincsuffici
subject
receiv
month
placebo
supplement
respect
lane
five
six
seven
eight
repres
zincdefici
zincsuffici
subject
receiv
month
zinc
supplement
respect
result
indic
month
zinc
supplement
increas
b
c
mrna
zincdefici
elderli
subject
compar
placebo
p
reproduc
prasad
bao
b
beck
fwj
sarkar
fh
correct
gene
express
vitro
zinc
addit
mnc
zinc
defici
human
subject
specif
test
zinc
defici
human
transl
re
zn
studi
effect
zinc
deplet
replet
zinc
balanc
data
point
repres
averag
valu
eight
subject
baselin
month
zinc
deplet
seven
subject
month
month
zinc
deplet
three
subject
zincreplet
period
valu
share
letter
significantli
differ
p
scheff
contrast
reproduc
lee
dy
prasad
hydrickadair
c
brewer
gj
johnson
pe
homeostasi
zinc
margin
human
zinc
defici
role
absorpt
endogen
excret
zinc
j
lab
clin
med
mrna
effect
vitro
addit
zn
mn
fe
cu
mrna
elderli
subject
human
mnc
isol
zincdefici
zincsuffici
elderli
subject
either
zn
chlorid
mn
chlorid
fe
sulfat
cu
sulfat
ad
isol
mnc
h
follow
pha
stimul
anoth
h
total
rna
extract
sampl
subject
rtpcr
analysi
data
shown
repres
three
subject
group
lane
one
repres
mnc
zincdefici
subject
lane
two
five
repres
mnc
zincdefici
subject
either
zn
mn
fe
cu
ad
media
lane
six
mnc
zincsuffici
subject
zn
addit
media
result
indic
zinc
addit
mn
fe
cu
increas
b
c
mrna
mnc
zincdefici
subject
p
reproduc
prasad
bao
b
beck
fwj
sarkar
fh
correct
gene
express
vitro
zinc
addit
mnc
zinc
defici
human
subject
specif
test
zinc
defici
human
transl
re
zn
studi
effect
zinc
deplet
replet
zinc
absorpt
use
stabl
zinc
isotop
zn
data
point
repres
averag
valu
eight
subject
baselin
month
zinc
deplet
seven
subject
month
month
zinc
deplet
three
subject
zincreplet
period
valu
share
letter
significantli
differ
p
scheff
contrast
reproduc
lee
dy
prasad
hydrickadair
c
brewer
gj
johnson
pe
homeostasi
zinc
margin
human
zinc
defici
role
absorpt
endogen
excret
zinc
j
lab
clin
med
zn
studi
effect
zinc
deplet
replet
endogen
zinc
excret
see
method
calcul
data
point
repres
averag
valu
eight
subject
baselin
month
zinc
deplet
seven
subject
month
month
zinc
deplet
three
subject
zincreplet
period
valu
share
letter
significantli
differ
p
scheff
contrast
reproduc
lee
dy
prasad
hydrickadair
c
brewer
gj
johnson
pe
homeostasi
zinc
margin
human
zinc
defici
role
absorpt
endogen
excret
zinc
j
lab
clin
med
summari
studi
experiment
model
human
zinc
defici
suggest
measur
serum
activ
thymulin
lymphocyt
nt
enzym
activ
assay
cytokin
express
mrna
endogen
excret
zinc
sensit
indic
acut
zinc
defici
statu
measur
zinc
level
lymphocyt
granulocyt
platelet
use
less
sensit
immunolog
assay
mention
chapter
